We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Cenix BioScience Follows up Successful RNAi-based Target Discovery Screens with Target Validation Study for AstraZeneca.

News   Mar 20, 2009

 
Cenix BioScience Follows up Successful RNAi-based Target Discovery Screens with Target Validation Study for AstraZeneca.
 
 
Advertisement
 

RELATED ARTICLES

Survey Highlights the Effects of COVID-19 Pandemic on Life Scientists

News

Jan Korbel and Oliver Stegle, both group leaders at EMBL Heidelberg, have performed a survey of fellow life scientists in Germany, Spain, the UK, Italy, France, Canada, Turkey, and the USA to learn how the current crisis, with partial or complete institutional shutdowns, is affecting their work.

READ MORE

New Insights Into RNA Movements Could Be Used To Treat Cancer

News

New research suggests that an RNA molecule involved in preventing tumor formation can change its structure and thereby control protein production in the cell, which could have implications for cancer treatment.

READ MORE

RNA Molecules in Maternal Blood May Predict Pregnancies at Risk for Preeclampsia

News

Study finds that microRNA biomarkers in asymptomatic pregnant women might reveal higher risk for the common and serious pregnancy complication; early identification could lead to prevention and better maternal and newborn outcomes.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE